Staging procedures in primary breast cancer

Anticancer Research

Volumn 28, Issue 4 C, 2008, Pages 2397-2400

  Müller, Daniela ^a,b   Köhler, Günter ^a   Ohlinger, Ralf ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

^b NONE   (Germany)

Author keywords

Bone scan; Liver ultrasound; Metastatic disease; Primary breast cancer; Staging; X ray

Indexed keywords

ADULT; AGED; ARTICLE; BONE SCINTISCANNING; BREAST CANCER; BREAST METASTASIS; CANCER DIAGNOSIS; CANCER PATIENT; CANCER SCREENING; CANCER SIZE; CANCER STAGING; DOPPLER ECHOGRAPHY; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MEDICAL RECORD REVIEW; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCREENING TEST; THORAX RADIOGRAPHY;

BREAST NEOPLASMS; FEMALE; HUMANS; LYMPHATIC METASTASIS; NEOPLASM METASTASIS; NEOPLASM STAGING; RETROSPECTIVE STUDIES;

EID: 48849110211     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Houlston RS, McCarter E, Parbhoo S, Scurr JH and Slack J: Family history and risk of breast cancer. J Med Genet 29: 154-157, 1992.
2. Kerlikowske K, Grady D, Barclay J, Sickles EA, Eaton A and Ernster V: Positive predictive value of screening mammography by age and family history of breast cancer. JAMA 270: 2444-2450, 1993.
3. Kerlikowske K, Grady D, Rubin SM, Sandrock C and Ernster VL: Efficacy of screening mammography. A meta-analysis. JAMA 273: 149-154, 1995.
4. Thomssen C: Incidence and mortality of breast cancer. What did we achieve? Der Gynäkologe 35: 680-688, 2002 (in German).
5. Bundred NJ: Prognostic and predictive factors in breast cancer. Cancer Treat Rev 27: 137-142, 2001.
6. Carter CL, Allen C and Henson DE: Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer 63: 181-187, 1989.
7. Clark GM, Sledge GW Jr, Osborne CK and McGuire WL: Survival from first recurrence: relative importance of prognostic factors in 1,015 breast cancer patients. J Clin Oncol 5: 55-61, 1987.
8. Elston CW and Ellis IO: Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 19: 403-410, 1991.
9. Koscielny S, Tubiana M, Le MG, Valleron AJ, Mouriesse H, Contesso G and Sarrazin D: Breast cancer: relationship between the size of the primary tumour and the probability of metastatic dissemination. Br J Cancer 49: 709-715, 1984.
10. Barry MC, Thornton F, Murphy M, Younis F and Watson RG: The value of metastatic screening in early primary breast cancer. Ir J Med Sci 168: 248-250, 1999.
11. Puglisi F, Follador A, Minisini AM, Cardellino GG, Russo S, Andreetta C, Di Terlizzi S and Piga A: Baseline staging tests after a new diagnosis of breast cancer: further evidence of their limited indications. Ann Oncol 16: 263-266, 2005.
12. Samant R and Ganguly P: Staging investigations in patients with breast cancer: the role of bone scans and liver imaging. Arch Surg 134: 551-553, 1999.
13. Schneider C, Fehr MK, Steiner RA, Hagen D, Haller U and Fink D: Frequency and distribution pattern of distant metastases in breast cancer patients at the time of primary presentation. Arch Gynecol Obstet 269: 9-12, 2003.
14. Ravaioli A, Pasini G, Polselli A, Papi M, Tassinari D, Arcangeli V, Milandri C, Amadori D, Bravi M, Rossi D, Fattori PP, Pasquini E and Panzini I: Staging of breast cancer: new recommended standard procedure. Breast Cancer Res Treat 72: 53-60, 2002.
15. Kassenärztliche Bundesvereinigung: EBM. http://www.kbv.de/ebm2008/ ebmgesamt.htm (2008).
16. Fisher B, Slack NH and Bross ID: Cancer of the breast: size of neoplasm and prognosis. Cancer 24: 1071-1080, 1969.
17. Abuzallouf S, Motawy M and Thotathil Z: Baseline staging of newly diagnosed breast cancer - Kuwait Cancer Control Center experience. Med Princ Pract 16: 22-24, 2007.
18. Berclaz G, Hofmann C, Aebi S, Brügger S, Fey M, Hänggi E and Dreher E: Staging breast cancer: Too many studies? Geburtshilfe und Frauenheilkunde 60: 418-422, 2000 (in German).
19. Gerber B, Seitz E, Muller H, Krause A, Reimer T, Kundt G and Friese K: Perioperative screening for metastatic disease is not indicated in patients with primary breast cancer and no clinical signs of tumor spread. Breast Cancer Res Treat 82: 29-37, 2003.
20. Ravaioli A, Tassinari D, Pasini G, Polselli A, Papi M, Fattori PP, Pasquini E, Masi A, Alessandrini F, Canuti D, Panzini I and Drudi G: Staging of breast cancer: what standards should be used in research and clinical practice? Ann Oncol 9: 1173-1177, 1998.
21. Koizumi M, Yoshimoto M, Kasumi F and Ogata E: What do breast cancer patients benefit from staging bone scintigraphy? Jpn J Clin Oncol 31: 263-269, 2001.
22. Lee JE, Park SS, Han W, Kim SW, Shin HJ, Choe KJ, Oh SK, Youn YK, Noh DY and Kim SW: The clinical use of staging bone scan in patients with breast carcinoma: reevaluation by the 2003 American Joint Committee on Cancer staging system. Cancer 104: 499-503, 2005.
23. Myers RE, Johnston M, Pritchard K, Levine M and Oliver T: Baseline staging tests in primary breast cancer: a practice guideline. CMAJ 164: 1439-1444, 2001.
24. Yeh KA, Fortunato L, Ridge JA, Hoffman JP, Eisenberg BL and Sigurdson ER: Routine bone scanning in patients with T1 and T2 breast cancer: a waste of money. Ann Surg Oncol 2: 319-324, 1995.
25. Puglisi F, Andreetta C, Fasola G, Cattaruzzi E and Geatti O: Bone scan for baseline staging in invasive breast cancer at the time of primary presentation. Breast Care 2: 358-364, 2007.
26. Bares R: Skeletal scintigraphy in breast cancer management. Q J Nucl Med 42: 43-48, 1998.
27. Dieterich M and Gerber B: Radiodiagnostics in the follow-up of breast cancer patients. Breast Care 2: 365-370, 2007.